| 1 |
Estimation of Undiagnosed Naegleria fowleri Primary Amebic Meningoencephalitis, United States<sup>1</sup>. ( 29260676
)
|
Matanock A....Cope J.R.
|
2018 |
| 2 |
Nurse's guide to primary amebic meningoencephalitis. ( 29561369
)
|
Peterson K....Heavey E.
|
2018 |
| 3 |
Primary Amebic Meningoencephalitis Associated With Rafting on an Artificial Whitewater River: Case Report and Environmental Investigation. ( 29401275
)
|
Cope J.R....Hill V.R.
|
2018 |
| 4 |
Identification and molecular typing of Naegleria fowleri from a patient with primary amebic meningoencephalitis in China. ( 29751112
)
|
|
2018 |
| 5 |
PAM-OBG: A monoamine oxidase B specific prodrug that inhibits MGMT and generates DNA interstrand crosslinks, potentiating temozolomide and chemoradiation therapy in intracranial glioblastoma. ( 29844863
)
|
Sharpe MA...Baskin DS
|
2018 |
| 6 |
Effect of SLC34A2 gene mutation on extracellular phosphorus transport in PAM alveolar epithelial cells. ( 29375690
)
|
Ma T...Hu Y
|
2018 |
| 7 |
Underwater wireless optical communication using an arrayed transmitter/receiver and optical superimposition-based PAM-4 signal. ( 29401841
)
|
Kong M...Xu J
|
2018 |
| 8 |
Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. ( 29512652
)
|
Hu JH...Liu DR
|
2018 |
| 9 |
Silicon photonic dual-drive MIM based 56 Gb/s DAC-less and DSP-free PAM-4 transmission. ( 29529742
)
|
Li R...Plant DV
|
2018 |
| 10 |
Low-cost and miniaturized 100-Gb/s (2 × 50 Gb/s) PAM-4 TO-packaged ROSA for data center networks. ( 29529810
)
|
Kang SK...Lee JK
|
2018 |
| 11 |
SaCas9 Requires 5'-NNGRRT-3' PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity than SpCas9 or FnCpf1 in Human Cells. ( 29544034
)
|
Xie H...Song Z
|
2018 |
| 12 |
Plant Genome Editing Using FnCpf1 and LbCpf1 Nucleases at Redefined and Altered PAM Sites. ( 29567452
)
|
Zhong Z...Qi Y
|
2018 |
| 13 |
Cas4 Facilitates PAM-Compatible Spacer Selection during CRISPR Adaptation. ( 29590607
)
|
Kieper SN...Brouns SJJ
|
2018 |
| 14 |
Digital chromatic dispersion pre-management enabled single-lane 112 Gb/s PAM-4 signal transmission over 80 km SSMF. ( 29601013
)
|
Fu S...Liu D
|
2018 |
| 15 |
Optical single side-band Nyquist PAM-4 transmission using dual-drive MZM modulation and direct detection. ( 29609350
)
|
Zhu M...Qiu K
|
2018 |
| 16 |
|
Srivastava R
|
2018 |
| 17 |
PAM: A Framework for Integrated Analysis of Imaging, Single-Molecule, and Ensemble Fluorescence Data. ( 29642023
)
|
Schrimpf W...Lamb DC
|
2018 |
| 18 |
A Novel M1 PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity. ( 29701957
)
|
Rook JM...Lindsley CW
|
2018 |
| 19 |
Harnessing biosynthesis and quantitative NMR for late stage functionalization of lead molecules: Application to the M1 positive allosteric modulator (PAM) program. ( 29716781
)
|
Brodney MA...Scott Obach R
|
2018 |
| 20 |
Corrigendum to "Microwave initiated synthesis of polyacrylamide grafted carboxymethylstarch (CMS-g-PAM): Application as a novel matrix for sustained drug release" [Int. J. Biol. Macromol. 45 (2009) 48-55]. ( 29801919
)
|
Sen G...Pal S
|
2018 |
| 21 |
Experimental demonstration of 20-Gb/s dual-band Nyquist PAM-4 transmission over a short-reach IMDD system using super-Nyquist sampling technique. ( 29856382
)
|
Deng R...Xin X
|
2018 |
| 22 |
Cas4 Nucleases Define the PAM, Length, and Orientation of DNA Fragments Integrated at CRISPR Loci. ( 29883605
)
|
Shiimori M...Terns MP
|
2018 |
| 23 |
PAM-Antagonists: A Better Way to Block Pathological Receptor Signaling? ( 29885909
)
|
Kenakin T...Strachan RT
|
2018 |
| 24 |
The role of sodium carbonate in PAM coagulation-flocculation for oil acidized wastewater treatment. ( 29944132
)
|
Qin J...Qian H
|
2018 |
| 25 |
PAM forms an atypical SCF ubiquitin ligase complex that ubiquitinates and degrades NMNAT2. ( 29997255
)
|
Desbois M...Grill B
|
2018 |
| 26 |
Type 2 diabetes risk alleles in PAM impact insulin release from human pancreatic β-cells. ( 30054598
)
|
Thomsen SK...Gloyn AL
|
2018 |
| 27 |
Evaluating the broad-spectrum efficacy of the acetylcholinesterase oximes reactivators MMB4 DMS, HLö-7 DMS, and 2-PAM Cl against phorate oxon, sarin, and VX in the Hartley guinea pig. ( 30056178
)
|
Wilhelm CM...Yeung DT
|
2018 |
| 28 |
Mixed cationic liposomes for brain delivery of drugs by the intranasal route: The acetylcholinesterase reactivator 2-PAM as encapsulated drug model. ( 30059851
)
|
Pashirova TN...Sinyashin OG
|
2018 |
| 29 |
Radial basis function neural network enabled C-band 4 × 50 Gb/s PAM-4 transmission over 80 km SSMF. ( 30067705
)
|
Yang Z...Liu D
|
2018 |
| 30 |
Radiosynthesis, ex Vivo Biodistribution, and in Vivo Positron Emission Tomography Imaging Evaluations of [11C]2-Pyridinealdoxime Methiodide ([11C]2-PAM): A First-In-Class Antidote Tracer for Organophosphate Intoxication. ( 30071719
)
|
Neumann KD...Gerdes JM
|
2018 |
| 31 |
Corrigendum to "Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides" [Bioorg. Med. Chem. Lett. 27(23) (2017) 5179-5184]. ( 30076050
)
|
Tarr JC...Lindsley CW
|
2018 |
| 32 |
In Silico Processing of the Complete CRISPR-Cas Spacer Space for Identification of PAM Sequences. ( 30076736
)
|
Mendoza BJ...Trinh CT
|
2018 |
| 33 |
PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures. ( 30109815
)
|
Gleditzsch D...Randau L
|
2018 |
| 34 |
Performance of M-PAM FSO communication systems in atmospheric turbulence based on APD detector. ( 30184878
)
|
Yao H...Jiang H
|
2018 |
| 35 |
Transmitter and receiver DSP for 112 Gbit/s PAM-4 amplifier-less transmissions using 25G-class EML and APD. ( 30184924
)
|
Huo J...Lu C
|
2018 |
| 36 |
Mb- and FnCpf1 nucleases are active in mammalian cells: activities and PAM preferences of four wild-type Cpf1 nucleases and of their altered PAM specificity variants. ( 30239882
)
|
T?th E...Welker E
|
2018 |
| 37 |
VU6007477, a Novel M1 PAM Based on a Pyrrolo[2,3-b]pyridine Carboxamide Core Devoid of Cholinergic Adverse Events. ( 30258541
)
|
Engers JL...Lindsley CW
|
2018 |
| 38 |
Novel deletion of SLC34A2 in Chinese patients of PAM shares mutation hot spot with fusion gene SLC34A2-ROS1 in lung cancer. ( 30262706
)
|
Dandan S...Fengjun T
|
2018 |
| 39 |
A pH-sensitive luminal His-cluster promotes interaction of PAM with V-ATPase along the secretory and endocytic pathways of peptidergic cells. ( 30317586
)
|
Rao VK...Eipper BA
|
2018 |
| 40 |
Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis. ( 30370423
)
|
Blum K...Badgaiyan RD
|
2018 |
| 41 |
Comparative evaluation of antidotal efficacy of 2-PAM and HNK-102 oximes during inhalation of sarin vapor in Swiss albino mice. ( 30375901
)
|
Swami D...Kumar P
|
2018 |
| 42 |
Minimal PAM specificity of a highly similar SpCas9 ortholog. ( 30397647
)
|
Chatterjee P...Jacobson JM
|
2018 |
| 43 |
B-973, a Novel α7 nAChR Ago-PAM: Racemic and Asymmetric Synthesis, Electrophysiological Studies, and in Vivo Evaluation. ( 30429960
)
|
Garai S...Thakur GA
|
2018 |
| 44 |
Pair Matcher (PaM): fast model-based optimisation of treatment/case-control matches. ( 30445488
)
|
Elhaik E...Ryan DM
|
2018 |
| 45 |
120 Gbaud PAM-4 transmission over 80-km SSMF using optical band interleaving and Kramers-Kronig detection. ( 30469687
)
|
Gui T...Lau APT
|
2018 |
| 46 |
A Parallel Architecture for the Partitioning Around Medoids (PAM) Algorithm for Scalable Multi-Core Processor Implementation with Applications in Healthcare. ( 30477277
)
|
Mushtaq H...Khan SA
|
2018 |
| 47 |
Partnership for mental health development in Sub-Saharan Africa (PaM-D): a collaborative initiative for research and capacity building. ( 30479242
)
|
Gureje O...Esan O
|
2018 |
| 48 |
The discovery of VU0652957 (VU2957, Valiglurax): SAR and DMPK challenges en route to an mGlu4 PAM development candidate. ( 30503632
)
|
Panarese JD...Lindsley CW
|
2018 |
| 49 |
Genome editing in plants by engineered CRISPR-Cas9 recognizing NG PAM. ( 30531939
)
|
Endo M...Toki S
|
2018 |
| 50 |
How adults with cardiac conditions in Singapore understand the Patient Activation Measure (PAM-13) items: a cognitive interviewing study. ( 27973921
)
|
Ngooi BX...Lim SP
|
2018 |
